5th Call for TRANSVAC Vaccine Development Services
TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines.
top of page
NEWS
News
Search
EVI
- Feb 4, 2019
- 1 min
EVI to co-lead new CEPI project with University of Tokyo to develop vaccine against Nipah virus
CEPI awards contract worth up to US$ 31 million to develop vaccine against Nipah virus.
EVI
- Jan 28, 2019
- 2 min
Workshop on “In vivo imaging of host response to vaccines and infections”
Workshop will concentrate on latest advances in non-invasive imaging technologies.
EVI
- Jan 23, 2019
- 1 min
Training in vaccine research and development
3rd Call for TRANSVAC Training Modules now advertised.
EVI
- Jan 21, 2019
- 1 min
Three PhD fellowships within MMVC programme
The Multi-Stage Malaria Vaccine Consortium (MMVC) offers 3 PhD Fellowships in Malaria Research.
EVI
- Jan 14, 2019
- 1 min
First clinical results of PlacMalVac project published
EVI-supported project publishes first clinical results for vaccine candidate to prevent pregnancy-associated malaria.
EVI
- Dec 27, 2018
- 1 min
TRANSVAC2 success story published by EC
European Commission highlights that EU-funded TRANSVAC2 project.
EVI
- Dec 4, 2018
- 1 min
TDR Clinical Research & Development Fellowships
Deadline for submission: 7 March 2019, 16:00 (GMT)
EVI
- Nov 15, 2018
- 1 min
EVI
- Jul 18, 2018
- 1 min
First pre-clinical results of the PRIMALVAC project published
New article published on in npj Vaccines
EVI
- Jun 14, 2018
- 1 min
SEmalvac2 & SEmalvac Annual Meeting 2018
The annual meeting of the GHIT-funded SEmalvac2 and SEmalvac projects was successfully held on 29-30 May in Ouagadougou, Burkina Faso.
EVI
- Jun 10, 2018
- 1 min
PREV_PKDL Kick-off meeting
The European and African partners of the EDCTP-funded project PREV_PKDL met at the University of York (United Kingdom) on 07-08 June 2018.
EVI
- May 24, 2018
- 1 min
Data protection & GDPR
EVI and Processing personal data on the basis of the EU/EEA General Data Protection Regulation.
EVI
- May 15, 2018
- 3 min
European-African partnership to advance the development of a Leishmania vaccine
Phase II clinical trials in Sudan of a therapeutic vaccine to prevent post kala azar dermal leishmaniasis to be supported by EDCTP.
EVI
- May 3, 2018
- 1 min
EVI 20th Anniversary Symposium
EVI's 20th Anniversary Symposium will take place on 20-21 November 2018 in Heidelberg, Germany.
EVI
- Apr 24, 2018
- 2 min
World Malaria Day 2018: Call for further stepping up investments
On the 10th anniversary of the Word Malaria Day, EVI announces that two malaria vaccine candidates have made important progress.
EVI
- Apr 22, 2018
- 1 min
TRANSVAC2 Animation movie
This short movie explains you what the whole initiative is about.
EVI
- Mar 20, 2018
- 1 min
Recommendations on the design of multi-centre validation studies
VAC2VAC project recommendations published in Biologicals.
EVI
- Feb 13, 2018
- 1 min
Sustained support by SAP business ByDesign to EVI’s mission
EVI’s financial reporting is now streamlined and more efficient.
EVI
- Dec 13, 2017
- 1 min
ZIKAVAX Annual Meeting 2017
The first annual meeting of the EU-funded project ZIKAVAX took place on 7 December 2017 at CEA, Fontenay-aux-Roses, France.
EVI
- Nov 19, 2017
- 1 min
MVVC2 study published
EDCTP funded MVVC2 study published today in Frontiers in Immunology.
EVI
- Oct 31, 2017
- 1 min
New funding to support novel DNA vaccine for therapy of leishmaniasis
Funding has been awarded by the GHIT Fund to complete preclinical development and for preparing Phase I Clinical Trial.
EVI
- Oct 18, 2017
- 1 min
EDUFLUVAC Final Meeting
EDUFLUVAC partners met for the final project meeting on 09-10 October in Brussels, Belgium.
EVI
- Oct 3, 2017
- 1 min
Report on Role and Impact of EU's 'Poverty-Related and Neglected Diseases' projects
EU Research Framework Programme activities in the field of Poverty-Related and Neglected Diseases.
bottom of page